Contactless Measurement of Heart Rate, Heart Rate Variability and Breathing Rate Using Remote Photoplethysmography
NCT ID: NCT05889832
Last Updated: 2024-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
136 participants
INTERVENTIONAL
2023-04-26
2023-06-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Contactless Measurement of Heart Rate, Heart Rate Variability, Breathing Rate and Blood Pressure Using Remote Photoplethysmography
NCT06829615
Non-contact Blood Pressure and SpO2 Measurement Based on Image Sensor
NCT06204822
Validation of the Performance of the COBOX Solution for Measuring Heart Rate and Respiratory Rate
NCT05528042
Evaluation of Performance, Usability, and Reliability of a Novel Device for Continuous Collection of Physiological Data
NCT03257189
Validity and Reliability of Optical Heart Rate Sensors
NCT05525000
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The measurements will be taken with various camera-equipped devices (smartphones, tablets, laptops) using either front camera (self-measurement) or rear camera (measurement made by someone else), in two different lighting conditions (artificial light or natural daylight), with various levels of device stability (fully stable or held in hand/s), and in two different body positions (sitting or supine). In total, each participant will have 8 measurements taken.
Standard deviation of normal heartbeat intervals (SDNN) will be used as the main HRV index.
Apart from the average HR (averaged over the whole 1-minute measurement), instantaneous values of HR (averaged over 10 s) will also be determined and displayed every 1 s by the Shen.AI VItals software.
In all cases, reference measurements will be taken simultaneously (chest ECG for the calculation of average and instantaneous HR as well as HRV; impedance pneumography for the determination of BR).
The reference measurements will be taken with Finapres Nova with the ECG+Resp module (Finapres Medical Systems B.V.).
For each measured parameter, the results from both methods will be compared using the Bland-Altman analysis or non-parametric limits of agreement.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HR, HRV and BR measured with Shen.AI and reference method
measurement of physiological parameters wih Shen.AI Vitals software on various camera-equipped devices (smartphones, tablets, laptops)
Resting heart rate (HR), heart rate variability (HRV) and breathing rate (BR) will be measured (estimated) with the use of remote photoplethysmography (1-minute face video analysis with Shen.AI Vitals software).
Reference measurements will be taken simultaneously (chest ECG for the calculation of HR and HRV; impedance pneumography for BR).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
measurement of physiological parameters wih Shen.AI Vitals software on various camera-equipped devices (smartphones, tablets, laptops)
Resting heart rate (HR), heart rate variability (HRV) and breathing rate (BR) will be measured (estimated) with the use of remote photoplethysmography (1-minute face video analysis with Shen.AI Vitals software).
Reference measurements will be taken simultaneously (chest ECG for the calculation of HR and HRV; impedance pneumography for BR).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ability to read and write in Polish or English
* ability to operate a smartphone, tablet and laptop without the need for glasses
* ability to understand the study procedure
* ability to communicate and follow the instructions of the study staff
* written consent to participate in the study and to the processing of personal data by the research team and the sponsor of the study
Exclusion Criteria
* failure to comply with the study procedure or the instructions of the study stuff
* extensive facial skin damage (including abrasions, wounds, burns)
* a disease process involving a large part of the face that makes the video- based measurement impossible
* extensive face dressing
* extensive facial skin tattoo or face painting
* marked deformation of the face (e.g. a tumor)
* inability to keep the head stable in the required position during the measurement
* persistent cough making it impossible to remain still during the measurement
* respiratory dysfunction in the form of shortness of breath or irregular or shallow breathing
* diagnosed arrhythmia (except sinus bradycardia or tachycardia)
* moderate or severe anemia
* diagnosed: heart failure, left ventricular systolic dysfunction, aortic stenosis or other diseases or disorders within the heart vascular system leading to decreased stroke volume, low pressure amplitude or the so-called paradoxical pulse
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SHEN.AI spółka z ograniczoną odpowiedzialnością oddział w Polsce
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bartłomiej Paleczny
Role: PRINCIPAL_INVESTIGATOR
Wrocław Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uniwersyteckie Centrum Wsparcia Badań Klinicznych we Wrocławiu
Wroclaw, Lower Silesian Voivodeship, Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MDF-01-008-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.